Drug-Induced Nephropathy

Drug-induced nephropathy is kidney injury caused by medications and other therapeutic agents. The kidney is especially vulnerable to drug toxicity because of its high blood flow and its role in concentrating and excreting drugs, and a wide range of medicines can injure the kidney through distinct mechanisms. It is a common and often preventable contributor to acute kidney injury, particularly in hospitalized patients.

Definition

Drug-induced nephropathy is renal injury, acute or chronic, attributable to exposure to a medication or therapeutic agent, occurring through identifiable toxic, ischaemic, immune, or obstructive mechanisms.

Scope

The topic covers why the kidney is susceptible to drug toxicity, the principal mechanisms of injury (haemodynamic, direct tubular toxicity, acute interstitial nephritis, crystal and obstructive injury, and thrombotic microangiopathy), the patterns of injury different drug classes tend to cause, and the concept of preventability. It is a reference and educational entry and gives no dosing, monitoring, or individualized prescribing advice.

Core questions

• Why is the kidney particularly exposed to drug toxicity compared with other organs?
• Through which mechanisms do different drugs injure the kidney, and how do these map to patterns of injury?
• What features make drug-induced kidney injury distinct and, in many cases, preventable?

Key concepts

• Nephrotoxicity and renal susceptibility to drugs
• Haemodynamically mediated (pre-renal) injury
• Direct tubular toxicity (acute tubular injury)
• Drug-induced acute interstitial nephritis
• Crystal and obstructive nephropathy
• Drug-induced thrombotic microangiopathy
• Preventability and risk factors (volume depletion, pre-existing CKD, drug combinations)

Mechanisms

The kidney receives a large fraction of cardiac output and concentrates many drugs and their metabolites in the tubular lumen and interstitium, so it is exposed to high local drug concentrations. Injury follows several recognized routes: alteration of intrarenal haemodynamics that reduces filtration; direct toxicity to tubular epithelial cells; an immune-mediated acute interstitial nephritis triggered by the drug as an allergen; precipitation of drug crystals causing intratubular obstruction; and, for some agents, thrombotic microangiopathy. The pattern of injury tends to track with the drug class and its mechanism, and risk rises with volume depletion, pre-existing chronic kidney disease, advanced age, and combinations of nephrotoxic agents (Perazella & Rosner, 2022; Perazella, 2003; Izzedine et al., 2005).

Clinical relevance

Drug-induced nephropathy is important because it is common and frequently preventable, and because recognizing the mechanism explains the pattern of injury a given agent tends to cause. This entry is educational and describes mechanisms and risk concepts; it does not provide drug doses, monitoring intervals, or individualized prescribing or de-prescribing advice, which require clinical judgement.

Epidemiology

Medications are a frequent cause of acute kidney injury, accounting for a substantial proportion of hospital-acquired cases, with the burden concentrated among older patients, those with pre-existing kidney disease, and the critically ill who receive multiple nephrotoxic agents (Perazella & Rosner, 2022). Specific agent classes, including certain antimicrobials, antivirals, and chemotherapeutics, are recurrently implicated (Izzedine et al., 2005).

Evidence & guidelines

The evidence base is largely observational and mechanistic, summarized in narrative reviews of drug-induced acute kidney injury and its mechanisms; these emphasize recognition of patterns and modifiable risk factors (Perazella & Rosner, 2022; Perazella, 2003).

History

Awareness of drug nephrotoxicity grew alongside the expansion of modern pharmacotherapy in the twentieth century, with classic examples such as aminoglycoside tubular toxicity, analgesic nephropathy, and contrast-associated injury shaping the field. Successive reviews have refined the mechanistic classification of injury and the identification of high-risk agents and patients (Perazella, 2003; Perazella & Rosner, 2022).

Seminal works

• perazella-rosner-2022
• perazella-2003
• izzedine-2005

Frequently asked questions

Why is the kidney so vulnerable to drug-induced injury?

The kidney receives a large share of blood flow and concentrates drugs and their metabolites during excretion, exposing tubular and interstitial cells to high local drug levels; this, plus its role in filtration, makes it a frequent site of medication toxicity.

What are the main ways drugs damage the kidney?

Recognized mechanisms include reduced renal blood flow (haemodynamic injury), direct tubular toxicity, drug-induced acute interstitial nephritis, crystal or obstructive injury, and thrombotic microangiopathy. The pattern usually relates to the specific drug and its mechanism.